A Nonterminal Equine Mandibular Model of Bone Healing

Tiffany L. Sarrafian, Tanya C. Garcia, Erin E. Dienes, Brian G Murphy, Susan M Stover, Larry D Galuppo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: To develop a nonterminal large animal bone defect model for assessing the efficacy of regenerative and pharmacologic treatments designed to enhance bone healing. Study Design: In vivo experimental. Sample Population: Adult gelding horses (n=6). Methods: Under general anesthesia, using radiographic guidance, 13.5mm diameter bilateral, full thickness mandibular defects were created in 6 horses using a custom surgical jig and coring bit. After 16 weeks, under general anesthesia, 23mm diameter cores that encompassed the original healing defects and surrounding parent bone material were removed for evaluation. Oxytetracycline was administered 14 days before final core harvest to label bone-forming surfaces. Healing was qualitatively assessed from decalcified hematoxylin and eosin (H&E) stained and undecalcified fluorescent labeled sections. Trabecular to cortical bone fraction (Tb.V/Ct.V), bone volume fraction (BV/TV), tissue mineral density (TMD), and apparent bone mineral density (aBMD) were quantified using microcomputed tomography and compared between left and right sides using Wilcoxon signed rank test. Results: BV/TV was not significantly different between left and right-sided defects. Bone deposition occurred centripetally from the border of the original defect, filling 67%±16% (SD) of the defect at 16 weeks. Conclusion: This model has potential use for comparison of regenerative and pharmacologic products aimed to augment bone healing.

Original languageEnglish (US)
Pages (from-to)314-321
Number of pages8
JournalVeterinary Surgery
Volume44
Issue number3
DOIs
StatePublished - Apr 1 2015

Fingerprint

Horses
bones
horses
Bone and Bones
General Anesthesia
anesthesia
X-Ray Microtomography
Oxytetracycline
micro-computed tomography
Hematoxylin
Eosine Yellowish-(YS)
Nonparametric Statistics
geldings
bone density
Bone Density
oxytetracycline
Minerals
experimental design
minerals
Population

ASJC Scopus subject areas

  • veterinary(all)

Cite this

A Nonterminal Equine Mandibular Model of Bone Healing. / Sarrafian, Tiffany L.; Garcia, Tanya C.; Dienes, Erin E.; Murphy, Brian G; Stover, Susan M; Galuppo, Larry D.

In: Veterinary Surgery, Vol. 44, No. 3, 01.04.2015, p. 314-321.

Research output: Contribution to journalArticle

Sarrafian, Tiffany L. ; Garcia, Tanya C. ; Dienes, Erin E. ; Murphy, Brian G ; Stover, Susan M ; Galuppo, Larry D. / A Nonterminal Equine Mandibular Model of Bone Healing. In: Veterinary Surgery. 2015 ; Vol. 44, No. 3. pp. 314-321.
@article{f9881f820d5547eebf1cd2eca4b233de,
title = "A Nonterminal Equine Mandibular Model of Bone Healing",
abstract = "Objectives: To develop a nonterminal large animal bone defect model for assessing the efficacy of regenerative and pharmacologic treatments designed to enhance bone healing. Study Design: In vivo experimental. Sample Population: Adult gelding horses (n=6). Methods: Under general anesthesia, using radiographic guidance, 13.5mm diameter bilateral, full thickness mandibular defects were created in 6 horses using a custom surgical jig and coring bit. After 16 weeks, under general anesthesia, 23mm diameter cores that encompassed the original healing defects and surrounding parent bone material were removed for evaluation. Oxytetracycline was administered 14 days before final core harvest to label bone-forming surfaces. Healing was qualitatively assessed from decalcified hematoxylin and eosin (H&E) stained and undecalcified fluorescent labeled sections. Trabecular to cortical bone fraction (Tb.V/Ct.V), bone volume fraction (BV/TV), tissue mineral density (TMD), and apparent bone mineral density (aBMD) were quantified using microcomputed tomography and compared between left and right sides using Wilcoxon signed rank test. Results: BV/TV was not significantly different between left and right-sided defects. Bone deposition occurred centripetally from the border of the original defect, filling 67{\%}±16{\%} (SD) of the defect at 16 weeks. Conclusion: This model has potential use for comparison of regenerative and pharmacologic products aimed to augment bone healing.",
author = "Sarrafian, {Tiffany L.} and Garcia, {Tanya C.} and Dienes, {Erin E.} and Murphy, {Brian G} and Stover, {Susan M} and Galuppo, {Larry D}",
year = "2015",
month = "4",
day = "1",
doi = "10.1111/j.1532-950X.2014.12279.x",
language = "English (US)",
volume = "44",
pages = "314--321",
journal = "Veterinary Surgery",
issn = "0161-3499",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - A Nonterminal Equine Mandibular Model of Bone Healing

AU - Sarrafian, Tiffany L.

AU - Garcia, Tanya C.

AU - Dienes, Erin E.

AU - Murphy, Brian G

AU - Stover, Susan M

AU - Galuppo, Larry D

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Objectives: To develop a nonterminal large animal bone defect model for assessing the efficacy of regenerative and pharmacologic treatments designed to enhance bone healing. Study Design: In vivo experimental. Sample Population: Adult gelding horses (n=6). Methods: Under general anesthesia, using radiographic guidance, 13.5mm diameter bilateral, full thickness mandibular defects were created in 6 horses using a custom surgical jig and coring bit. After 16 weeks, under general anesthesia, 23mm diameter cores that encompassed the original healing defects and surrounding parent bone material were removed for evaluation. Oxytetracycline was administered 14 days before final core harvest to label bone-forming surfaces. Healing was qualitatively assessed from decalcified hematoxylin and eosin (H&E) stained and undecalcified fluorescent labeled sections. Trabecular to cortical bone fraction (Tb.V/Ct.V), bone volume fraction (BV/TV), tissue mineral density (TMD), and apparent bone mineral density (aBMD) were quantified using microcomputed tomography and compared between left and right sides using Wilcoxon signed rank test. Results: BV/TV was not significantly different between left and right-sided defects. Bone deposition occurred centripetally from the border of the original defect, filling 67%±16% (SD) of the defect at 16 weeks. Conclusion: This model has potential use for comparison of regenerative and pharmacologic products aimed to augment bone healing.

AB - Objectives: To develop a nonterminal large animal bone defect model for assessing the efficacy of regenerative and pharmacologic treatments designed to enhance bone healing. Study Design: In vivo experimental. Sample Population: Adult gelding horses (n=6). Methods: Under general anesthesia, using radiographic guidance, 13.5mm diameter bilateral, full thickness mandibular defects were created in 6 horses using a custom surgical jig and coring bit. After 16 weeks, under general anesthesia, 23mm diameter cores that encompassed the original healing defects and surrounding parent bone material were removed for evaluation. Oxytetracycline was administered 14 days before final core harvest to label bone-forming surfaces. Healing was qualitatively assessed from decalcified hematoxylin and eosin (H&E) stained and undecalcified fluorescent labeled sections. Trabecular to cortical bone fraction (Tb.V/Ct.V), bone volume fraction (BV/TV), tissue mineral density (TMD), and apparent bone mineral density (aBMD) were quantified using microcomputed tomography and compared between left and right sides using Wilcoxon signed rank test. Results: BV/TV was not significantly different between left and right-sided defects. Bone deposition occurred centripetally from the border of the original defect, filling 67%±16% (SD) of the defect at 16 weeks. Conclusion: This model has potential use for comparison of regenerative and pharmacologic products aimed to augment bone healing.

UR - http://www.scopus.com/inward/record.url?scp=84926650243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926650243&partnerID=8YFLogxK

U2 - 10.1111/j.1532-950X.2014.12279.x

DO - 10.1111/j.1532-950X.2014.12279.x

M3 - Article

VL - 44

SP - 314

EP - 321

JO - Veterinary Surgery

JF - Veterinary Surgery

SN - 0161-3499

IS - 3

ER -